U.S. flag

An official website of the United States government

NM_000159.4(GCDH):c.442G>A (p.Val148Ile) AND Glutaric aciduria, type 1

Germline classification:
Pathogenic/Likely pathogenic (4 submissions)
Last evaluated:
Dec 31, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003050529.6

Allele description [Variation Report for NM_000159.4(GCDH):c.442G>A (p.Val148Ile)]

NM_000159.4(GCDH):c.442G>A (p.Val148Ile)

Gene:
GCDH:glutaryl-CoA dehydrogenase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.13
Genomic location:
Preferred name:
NM_000159.4(GCDH):c.442G>A (p.Val148Ile)
HGVS:
  • NC_000019.10:g.12893590G>A
  • NG_009292.1:g.7431G>A
  • NM_000159.3:c.442G>A
  • NM_000159.4:c.442G>AMANE SELECT
  • NM_013976.5:c.442G>A
  • NP_000150.1:p.Val148Ile
  • NP_039663.1:p.Val148Ile
  • NC_000019.9:g.13004404G>A
  • NM_000159.4:c.442G>A
  • NR_102316.1:n.605G>A
  • NR_102317.1:n.858G>A
Protein change:
V148I
Molecular consequence:
  • NM_000159.4:c.442G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_013976.5:c.442G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_102316.1:n.605G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_102317.1:n.858G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Glutaric aciduria, type 1
Synonyms:
GA I; Glutaryl-CoA dehydrogenase deficiency; Glutaric acidemia type I; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009281; MedGen: C0268595; Orphanet: 25; OMIM: 231670

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003443120Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 31, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV004039399Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Aug 25, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link,

SCV004191001Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Oct 13, 2023)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005367967Molecular Genetics Laboratory, BC Children's and BC Women's Hospitals
no assertion criteria provided

(ACMG Guidelines, 2015)
Likely pathogenic
(Aug 7, 2024)
paternalclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedpaternalyesnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency.

Christensen E, Ribes A, Merinero B, Zschocke J.

J Inherit Metab Dis. 2004;27(6):861-8.

PubMed [citation]
PMID:
15505393
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003443120.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 148 of the GCDH protein (p.Val148Ile). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with glutaric aciduria type I (PMID: 9600243, 24332224). ClinVar contains an entry for this variant (Variation ID: 2138244). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GCDH protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004039399.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

Variant summary: GCDH c.442G>A (p.Val148Ile) results in a conservative amino acid change located in the Acyl-CoA dehydrogenase/oxidase, N-terminal domain (IPR013786) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251470 control chromosomes (gnomAD). c.442G>A has been reported in the literature in multiple bi-allelic individuals affected with Glutaric Acidemia Type 1 (examples: Schwartz_1998, Kolker_2006, Christensen_2004, and Wang_2014). These data indicate that the variant is very likely to be associated with disease. Multiple publications have reported experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal activity (examples: Schwartz_1998, Kolker_2006, Christensen_2004). The following publications have been ascertained in the context of this evaluation (PMID: 9600243, 16641220, 15505393, 24332224). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004191001.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Molecular Genetics Laboratory, BC Children's and BC Women's Hospitals, SCV005367967.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1paternalyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024